• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

How Do Clinical Characteristics of COVID-19 Infection Differ Between Symptomatic and Asymptomatic Patients?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Yang et al. (JAMA Netw Open., 2020) describe clinical characteristics of both symptomatic and asymptomatic patients with confirmed SARS-CoV-2 infection

METHODS:

  • Case series (December 24, 2019, to February 24, 2020)
  • Setting
    • Wuhan, China
  • Participants
    • Consecutive hospitalized cases with lab confirmed COVID-19
    • Recruited from 26 cluster cases who had
      • Confirmed history of exposure to the Hunan seafood market or
      • Close contact with another patient who had been hospitalized for COVID-19
  • Study design
    • RT-PCR on nasopharyngeal swabs was performed every 24 to 48 hours
    • CT scan: On admission with a second chest CT at 4 to 6 days and third CT at 6 to 7 days after the second scan
      • Additional CT for worsening status
    • CD4+T lymphocyte count was tested every 5 to 6 days

RESULTS:

  • 78 patients
    • Median (IQR) number of patients per cluster: 3 (2-3) patients
    • Range: 2 to 10 patients per cluster
  • Symptomatic vs asymptomatic
    • Symptomatic cases: 57.7% of cases (45 patients)
    • Asymptomatic: 42.3% of cases (33 patients)
  • Patients who were asymptomatic tended to
    • Be younger (P < 0.001)
      • Asymptomatic: median (IQR) age 37 (26 to 45) years
      • Symptomatic: 56 (34 to 63) years
    • Be women (P = 0.002)
      • Asymptomatic: 66.7% were women (22 patients)
      • Symptomatic: 31.0% were women (14 patients)
    • Not have biochemical evidence of liver injury (P = 0.03)
      • Asymptomatic: 3% had a liver injury (1 patient)
      • Symptomatic: 20.0% had a liver injury (9 patients)
    • Have higher CD4+T lymphocyte counts  (P = 0.001)
      • Asymptomatic: median (IQR) 719 (538 to 963) per uL
      • Symptomatic: 474 (354 to 811) per ul
    • Have faster lung recovery based on CT scan (P = 0.001)
      • Asymptomatic: median (IQR) duration 9 (6 to 18) days
      • Symptomatic: 15 (11 to 18) days
    • Have a shorter duration of viral shedding on nasopharyngeal swabs (P = 0.001)
      • Asymptomatic: median (IQR) duration 8 (3 to 12) days
      • Symptomatic: 19 (16 to 24) days
    • Have more stable SARS-CoV-2 testing results
      • Asymptomatic: 12.1% had fluctuated results (4 patients)
      • Symptomatic: 33.3% had fluctuated results (15 patients)

CONCLUSION:

  • Compared to symptomatic COVID-19 patients, asymptomatic patients experienced less organ injury and CT scans improved more rapidly
    • Consumption of CD4 lymphocytes was lower, suggesting less damage to the immune system
  • Asymptomatic patients appear to have a shorter duration of viral shedding, suggesting that they may be infectious for a shorter period of time

Learn More – Primary Sources:

Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China

Get COVID-19 Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

COVID-19: The Impact of Asymptomatic Cases on the Pandemic Outbreak
Labor & Delivery: Asymptomatic Patients and Universal COVID-19 Testing
CDC Weekly Update: Which Comorbidities are Associated with COVID-19 in the US?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site